4

What Is Lumvoa™? Everything Patients Should Know About This New Treatment for Thyroid Eye Disease

Jul 10, 2026 | Blog

A diagnosis of thyroid eye disease (TED) can bring many questions. What caused it? Will it get worse? What treatments are available? Fortunately, advances in medicine continue to provide new options for people living with TED. One of the newest is Lumvoa™ (veligrotug-vvze), an FDA-approved infusion therapy developed specifically for adults with thyroid eye disease. […]

A diagnosis of thyroid eye disease (TED) can bring many questions. What caused it? Will it get worse? What treatments are available? Fortunately, advances in medicine continue to provide new options for people living with TED. One of the newest is Lumvoa™ (veligrotug-vvze), an FDA-approved infusion therapy developed specifically for adults with thyroid eye disease.

We’re proud to provide access to Lumvoa at our infusion centers across New York, New Jersey, Pennsylvania, Connecticut, Florida, Ohio, Tennessee, Kentucky, and Vermont.

Here’s what you should know about this innovative treatment.

What Is Thyroid Eye Disease?

Thyroid eye disease is an autoimmune condition that causes inflammation and swelling of the muscles and tissues surrounding the eyes. Although it is often associated with Graves’ disease, thyroid eye disease can occur in people with a variety of thyroid disorders.

Common symptoms include:

  • Bulging eyes (proptosis)
  • Eye pain or pressure
  • Dry or irritated eyes
  • Double vision
  • Light sensitivity
  • Redness and swelling
  • Difficulty fully closing the eyelids
  • Vision changes

Symptoms vary from person to person, which is why treatment plans are individualized.

What Is Lumvoa?

Lumvoa is an FDA-approved biologic infusion therapy designed to treat thyroid eye disease by targeting one of the key drivers of inflammation.

Rather than simply managing symptoms, Lumvoa works by blocking the insulin-like growth factor-1 receptor (IGF-1R), which plays an important role in the disease process.

By addressing the underlying cause of inflammation, Lumvoa may help reduce:

  • Eye bulging
  • Double vision
  • Swelling
  • Eye discomfort
  • Overall disease activity

Your healthcare provider can determine whether Lumvoa is appropriate for your individual condition.

How Is Lumvoa Administered?

Lumvoa is given through an intravenous (IV) infusion at an outpatient infusion center under the supervision of trained healthcare professionals. Receiving treatment at a specialty infusion center allows patients to receive personalized monitoring while relaxing in a comfortable environment. At Thrivewell, our experienced infusion nurses are committed to making every treatment as smooth and stress-free as possible.

Living with thyroid eye disease doesn’t mean navigating treatment alone.

At Thrivewell Infusion, our mission is to provide exceptional infusion care in an environment that prioritizes comfort, compassion, and convenience. From scheduling your first appointment to supporting you throughout every infusion, our experienced team is committed to helping you receive the care you deserve.

If you’ve been prescribed Lumvoa or would like to learn more about treatment options for thyroid eye disease, contact Thrivewell Infusion today to find a location near you.

Frequently Asked Questions About Lumvoa

Is Lumvoa a biologic medication?

Yes. Lumvoa is a biologic infusion therapy used to treat thyroid eye disease.

Who can receive Lumvoa?

Your healthcare provider will determine if Lumvoa is an appropriate treatment based on your medical history and diagnosis.

Where is Lumvoa administered?

Lumvoa is administered by intravenous infusion at qualified infusion centers, such as Thrivewell Infusion.

Does Thrivewell offer Lumvoa?

Yes. Thrivewell Infusion proudly offers Lumvoa at locations across nine states.

Does Thrivewell help with insurance?

Yes. Our Patient Access team works directly with physicians, insurance providers, and specialty pharmacies to help coordinate the approval process.